Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Mar;84(3):293–299. doi: 10.1136/bjo.84.3.293

Effects of topical nipradilol, a β blocking agent with α blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans

M Kanno 1, M Araie 1, H Koibuchi 1, K Masuda 1
PMCID: PMC1723399  PMID: 10684841

Abstract

AIMS—To study the effects of topical nipradilol, a non-selective β blocker with α blocking and nitroglycerin-like activities, on intraocular pressure (IOP) and aqueous humour dynamics in normal humans and in patients with ocular hypertension.
METHODS—Nipradilol (0.06%, 0.125%, 0.25%, 0.5%) was applied to normal volunteers (n = 12) to test for IOP lowering effects. In a second group of normal volunteers (n = 11), nipradilol (0.125% and 0.25%) and timolol (0.5%) were compared for IOP lowering effects. After a single administration of 0.25% nipradilol, IOP, flare intensity in the anterior chamber, aqueous flow, uveoscleral outflow, tonographic outflow facility, and episcleral venous pressure were either directly measured or mathematically calculated. Topical nipradilol (0.25%) was administered to 24 patients with ocular hypertension twice daily for 8 weeks.
RESULTS—Administration of 0.25% nipradilol decreased IOP with a maximum reduction of 4.2 mm Hg lasting 12 hours. A single instillation of both 0.25% nipradilol and 0.5% timolol reduced the IOP in normotensive human subjects to the same degree. A single instillation of 0.25% nipradilol decreased the aqueous flow rate in the treated eye by 20%. Nipradilol produced no significant effect in tonographic outflow facility or episcleral venous pressure, but uveoscleral outflow was increased. In patients with ocular hypertension, twice daily instillation of 0.25% nipradilol decreased IOP without tachyphylaxis for the 8 week test period.
CONCLUSION—Topical nipradilol (0.25%) reduced IOP by decreasing the aqueous flow rate and probably also by increasing uveoscleral outflow. Nipradilol should be further investigated as a new antiglaucoma drug.



Full Text

The Full Text of this article is available as a PDF (162.7 KB).

Figure 1  .

Figure 1  

Open in a new tab

Reduction in the intraocular pressure after 0.125%, 0.25% nipradilol, or 0.5% timolol instillation in drug treated eye and vehicle treated eye. Δ Intraocular pressure = difference between the change from pretreatment values in the drug treated experiment (0.125% or 0.25% nipradilol or 0.5% timolol solution instilled in one eye and vehicle in fellow eye) and that in the control experiment (vehicle solutions instilled in both eyes). Figures are significantly negative, *p<0.05. Bars represent mean (SE) (mm Hg) in 11 eyes of 11 subjects.

Figure 2  .

Figure 2  

Open in a new tab

Intraocular pressure after twice daily instillation of 0.25% nipradilol during 8 weeks. Bars represent mean (SE) (mm Hg) in 24 eyes of 24 subjects. *Compared with week 0, v week 1; p=0.0016, v week 2; p=0.0022, v week 3; p<0.0001, v week 4; p<0.0001 (paired t test with Bonferroni's correction).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hayashi M., Yablonski M. E., Novack G. D. Trabecular outflow facility determined by fluorophotometry in human subjects. Exp Eye Res. 1989 May;48(5):621–625. doi: 10.1016/0014-4835(89)90004-3. [DOI] [PubMed] [Google Scholar]
  2. Jones R. F., Maurice D. M. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res. 1966 Jul;5(3):208–220. doi: 10.1016/s0014-4835(66)80009-x. [DOI] [PubMed] [Google Scholar]
  3. Kanno M., Araie M., Tomita K., Sawanobori K. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Invest Ophthalmol Vis Sci. 1998 Apr;39(5):736–743. [PubMed] [Google Scholar]
  4. Krupin T., Feitl M., Becker B. Effect of prazosin on aqueous humor dynamics in rabbits. Arch Ophthalmol. 1980 Sep;98(9):1639–1642. doi: 10.1001/archopht.1980.01020040491021. [DOI] [PubMed] [Google Scholar]
  5. Lam A. K., Douthwaite W. A. A pilot study on the measurement of central posterior corneal radius in Hong Kong Chinese using Purkinje image technique. Ophthalmic Physiol Opt. 1997 Jan;17(1):68–74. [PubMed] [Google Scholar]
  6. Mori M., Araie M. A simple method of determining the time course of timolol's effects on aqueous flow in humans. Arch Ophthalmol. 1991 Aug;109(8):1099–1103. doi: 10.1001/archopht.1991.01080080059028. [DOI] [PubMed] [Google Scholar]
  7. Nathanson J. A. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther. 1992 Mar;260(3):956–965. [PubMed] [Google Scholar]
  8. Ohira A., Wada Y., Fujii M., Nakamura M., Kasuya Y., Hamada Y., Shigenobu K. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues. Arch Int Pharmacodyn Ther. 1985 Nov;278(1):61–71. [PubMed] [Google Scholar]
  9. Oshika T., Araie M., Sugiyama T., Nakajima M., Azuma I. Effect of bunazosin hydrochloride on intraocular pressure and aqueous humor dynamics in normotensive human eyes. Arch Ophthalmol. 1991 Nov;109(11):1569–1574. doi: 10.1001/archopht.1991.01080110105046. [DOI] [PubMed] [Google Scholar]
  10. Oshika T., Araie M. Time course of changes in aqueous protein concentration and flow rate after oral acetazolamide. Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):527–534. [PubMed] [Google Scholar]
  11. Sakurai M., Araie M., Oshika T., Mori M., Masuda K., Ueno R., Takase M. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol. 1991;35(2):156–165. [PubMed] [Google Scholar]
  12. Schuman J. S., Erickson K., Nathanson J. A. Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res. 1994 Jan;58(1):99–105. doi: 10.1006/exer.1994.1199. [DOI] [PubMed] [Google Scholar]
  13. Scriabine A., Torchiana M. L., Stavorski J. M., Ludden C. T., Minsker D. H., Stone C. A. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent. Arch Int Pharmacodyn Ther. 1973 Sep;205(1):76–93. [PubMed] [Google Scholar]
  14. Serle J. B., Stein A. J., Podos S. M., Severin C. H. Corynanthine and aqueous humor dynamics in rabbits and monkeys. Arch Ophthalmol. 1984 Sep;102(9):1385–1388. doi: 10.1001/archopht.1984.01040031127039. [DOI] [PubMed] [Google Scholar]
  15. Shirasawa Y., Fujii M., Nakamura M. Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine. Jpn J Pharmacol. 1985 Sep;39(1):77–82. doi: 10.1254/jjp.39.77. [DOI] [PubMed] [Google Scholar]
  16. Smith B. R., Murray D. L., Leopold I. H. Influence of topically applied prazosin on the intraocular pressure of experimental animals. Arch Ophthalmol. 1979 Oct;97(10):1933–1936. doi: 10.1001/archopht.1979.01020020381023. [DOI] [PubMed] [Google Scholar]
  17. Taniguchi T., Deguchi T., Ogawa T., Kitazawa Y. [Effects of amosulalol hydrochloride on intraocular pressure and aqueous humor dynamics in the rabbit eye]. Nippon Ganka Gakkai Zasshi. 1996 Apr;100(4):279–283. [PubMed] [Google Scholar]
  18. Tomlinson A., Leighton D. A. Ocular dimensions and the heredity of open-angle glaucoma. Br J Ophthalmol. 1974 Jan;58(1):68–74. doi: 10.1136/bjo.58.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Uchida Y., Nakamura M., Shimizu S., Shirasawa Y., Fujii M. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Arch Int Pharmacodyn Ther. 1983 Mar;262(1):132–149. [PubMed] [Google Scholar]
  20. Zimmerman T. J., Kooner K. S., Kandarakis A. S., Ziegler L. P. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol. 1984 Apr;102(4):551–553. doi: 10.1001/archopht.1984.01040030429017. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES